SFJ Pharma Raises $45 Million


SFJ Pharmaceuticals Inc., a platform for bringing U.S. and European drugs to Japan, has raised $45 million in Series A funding, according to VentureWire. Abingworth Management and Clarus Ventures co-led the round, which was designed to help the company acquire its first products. www.sfj-pharma.com (website not currently active)

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.